ES2564227T3 - Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno - Google Patents

Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno Download PDF

Info

Publication number
ES2564227T3
ES2564227T3 ES11743651.9T ES11743651T ES2564227T3 ES 2564227 T3 ES2564227 T3 ES 2564227T3 ES 11743651 T ES11743651 T ES 11743651T ES 2564227 T3 ES2564227 T3 ES 2564227T3
Authority
ES
Spain
Prior art keywords
gene
dna
vector
antibody
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11743651.9T
Other languages
English (en)
Spanish (es)
Inventor
Daisuke Nishimiya
Tatsuya Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ES2564227T3 publication Critical patent/ES2564227T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51Complete heavy chain or Fd fragment, i.e. VH + CH1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515Complete light chain, i.e. VL + CL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • C12N2800/107Plasmid DNA for vertebrates for mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/46Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES11743651.9T 2010-07-07 2011-07-06 Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno Active ES2564227T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010154782 2010-07-07
JP2010154782 2010-07-07
PCT/JP2011/065916 WO2012005378A2 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Publications (1)

Publication Number Publication Date
ES2564227T3 true ES2564227T3 (es) 2016-03-21

Family

ID=44630215

Family Applications (3)

Application Number Title Priority Date Filing Date
ES11743651.9T Active ES2564227T3 (es) 2010-07-07 2011-07-06 Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
ES13186031.4T Active ES2565428T3 (es) 2010-07-07 2011-07-06 Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
ES15188915T Active ES2701091T3 (es) 2010-07-07 2011-07-06 Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES13186031.4T Active ES2565428T3 (es) 2010-07-07 2011-07-06 Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
ES15188915T Active ES2701091T3 (es) 2010-07-07 2011-07-06 Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno

Country Status (14)

Country Link
US (3) US9371543B2 (enExample)
EP (3) EP3026117B1 (enExample)
JP (2) JP5859988B2 (enExample)
KR (3) KR101856927B1 (enExample)
CN (3) CN105950621B (enExample)
AU (3) AU2011274864B2 (enExample)
BR (1) BR112012033780A2 (enExample)
CA (2) CA2804381C (enExample)
ES (3) ES2564227T3 (enExample)
IL (1) IL243763A0 (enExample)
RU (1) RU2013104989A (enExample)
SG (4) SG10201505354PA (enExample)
TW (2) TWI507523B (enExample)
WO (1) WO2012005378A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2564227T3 (es) * 2010-07-07 2016-03-21 Daiichi Sankyo Company, Limited Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
RU2014121383A (ru) 2011-11-28 2016-01-27 Дайити Санкио Компани, Лимитед Происходящий из гена человека промотор
CN109790539A (zh) * 2016-10-03 2019-05-21 第一三共株式会社 Hspa5基因的启动子
CN107881174B (zh) * 2017-11-22 2022-06-03 张宝会 一种翻译水平基因表达调控的方法及应用
AU2020447192A1 (en) * 2020-05-11 2023-01-19 Samsung Bioepis Co., Ltd. Human genome-derived polynucleotide and method for producing polypeptide of interest using same
CN119013400A (zh) 2022-04-26 2024-11-22 第一三共株式会社 Eno1基因的启动子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341251C (en) * 1988-02-12 2001-06-12 David Bernard Boyle Pox virus vectors
US20070161003A1 (en) * 2003-09-29 2007-07-12 Morris David W Novel therapeutic targets in cancer
EP2105742A1 (en) * 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
JP5344682B2 (ja) * 2008-12-26 2013-11-20 グローブライド株式会社 釣糸ガイド、及び釣糸ガイドの製造方法
ES2564227T3 (es) * 2010-07-07 2016-03-21 Daiichi Sankyo Company, Limited Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
RU2014121383A (ru) * 2011-11-28 2016-01-27 Дайити Санкио Компани, Лимитед Происходящий из гена человека промотор

Also Published As

Publication number Publication date
ES2565428T3 (es) 2016-04-04
RU2013104989A (ru) 2014-08-20
BR112012033780A2 (pt) 2016-05-31
EP2591113A2 (en) 2013-05-15
TW201604280A (zh) 2016-02-01
US20190345515A1 (en) 2019-11-14
JP6039048B2 (ja) 2016-12-07
TWI507523B (zh) 2015-11-11
EP2684961A1 (en) 2014-01-15
JP2013531967A (ja) 2013-08-15
JP5859988B2 (ja) 2016-02-16
CA2804381C (en) 2016-03-22
JP2016054741A (ja) 2016-04-21
CN103080321A (zh) 2013-05-01
US20130171694A1 (en) 2013-07-04
CA2916937A1 (en) 2012-01-12
SG10201505354PA (en) 2015-08-28
AU2018200686B2 (en) 2020-02-13
CN105950621A (zh) 2016-09-21
KR101833570B1 (ko) 2018-03-02
EP2684961B1 (en) 2016-01-20
ES2701091T3 (es) 2019-02-20
CN103865931A (zh) 2014-06-18
US20160333371A1 (en) 2016-11-17
US9371543B2 (en) 2016-06-21
AU2016203681B2 (en) 2018-04-19
EP3026117B1 (en) 2018-09-12
AU2018200686A1 (en) 2018-02-22
AU2011274864B2 (en) 2016-10-06
TW201207103A (en) 2012-02-16
US11060108B2 (en) 2021-07-13
AU2016203681A1 (en) 2016-06-23
IL243763A0 (en) 2016-04-21
KR101920187B1 (ko) 2018-11-19
KR20180021247A (ko) 2018-02-28
KR20180021246A (ko) 2018-02-28
KR101856927B1 (ko) 2018-05-10
WO2012005378A2 (en) 2012-01-12
EP2591113B1 (en) 2016-01-20
WO2012005378A3 (en) 2012-04-12
SG186788A1 (en) 2013-02-28
EP3026117A1 (en) 2016-06-01
AU2011274864A1 (en) 2013-02-07
KR20130111514A (ko) 2013-10-10
SG2014009187A (en) 2014-04-28
SG10201705118RA (en) 2017-07-28
CA2804381A1 (en) 2012-01-12
US10407694B2 (en) 2019-09-10
CN105950621B (zh) 2019-07-30
CN103865931B (zh) 2018-10-02

Similar Documents

Publication Publication Date Title
ES2564227T3 (es) Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
JP2015091238A (ja) 哺乳類発現ベクター
ES2670894T3 (es) Promotor derivado de un gen humano
EP3382026B1 (en) A novel cell line screening method
KR101608225B1 (ko) 신규한 재조합 서열
JP2006500937A (ja) ヒトの糖鎖付加パターンを有する遺伝子産物の発現のための高収量異種発現細胞系
WO2018066492A1 (ja) Hspa5遺伝子のプロモーター
ES2372703T3 (es) Fragmentos de adn que aumentan la expresión, uso de los mismos y procedimientos para encontrarlos.
Brewer GENE EXPRESSION: TRANSLATION, MRNA STABILITY, AND POLY (A) PROCESSING